Efficacy and safety of lactulose for the treatment of irritable bowel syndrome

Conclusions: This study will provide the evidence for the clinical efficacy and safety of lactulose for the treatment of IBS. PROSPERO registration number: PROSPERO CRD42019140639.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research